Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02617589 : An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
PhasePhase 3
AgesMin: 18 Years Max: N/A
Eligibility
For more information regarding BMS clinical trial participation, please visit
www.BMSStudyConnect.com

Inclusion Criteria:

- Males and Females, age ? 18 years old

- Newly-diagnosed brain cancer or tumor called glioblastoma or GBM

- Tumor test result shows MGMT unmethylated type

- Karnofsky performance status of ? 70 (able to care for self)

Exclusion Criteria:

- Prior treatment for GBM (other than surgical resection)

- Any known tumor outside of the brain

- Recurrent or secondary GBM

- Active known or suspected autoimmune disease

- Biopsy with less than 20% of tumor removed
LinksPermanent Link to THIS page: http://virtualtrials.com/nct/display1trial.cfm?nct=NCT02617589      |      Link to official Clinicaltrials.gov listing
Locations
Liverpool, New South Wales
Australia

Facility: Local Institution
Investigator:
Contact: Site 0002
Email not avaialable

St. Leonards, New South Wales
Australia

Facility: Royal North Shore Hospital
Investigator:
Contact: Mustafa Khasraw, Site 0005 Phone: +61294631373
Email not avaialable

Heidelberg, Victoria
Australia

Facility: Local Institution
Investigator:
Contact: Site 0003
Email not avaialable

Prahran, Victoria
Australia

Facility: Local Institution
Investigator:
Contact: Site 0004
Email not avaialable

Nedlands, Western Australia
Australia

Facility: Sir Charles Gairdner Hospital
Investigator:
Contact: Anna Nowak, Site 0001 Phone: +61408818656
Email not avaialable

Vancouver, British Columbia
Canada

Facility: British Columbia Cancer Agency-Vancouver Ctr
Investigator:
Contact: Brian Thiessen, Site 0014 Phone: 6048776000
Email not avaialable

Toronto, Ontario
Canada

Facility: Princess Margaret Cancer Centre
Investigator:
Contact: Warren Mason, Site 0035 Phone: 4165817823
Email not avaialable

Montreal, Quebec
Canada

Facility: Montreal Neurological Institute and Hospital
Investigator:
Contact: Kevin Petrecca, Site 0074 Phone: 5143982801
Email not avaialable

Bron Cedex,
France

Facility: Local Institution
Investigator:
Contact: Site 0032
Email not avaialable

Lille Cedex,
France

Facility: Local Institution
Investigator:
Contact: Site 0039
Email not avaialable

Marseille,
France

Facility: Local Institution
Investigator:
Contact: Site 0024
Email not avaialable

Paris,
France

Facility: Local Institution
Investigator:
Contact: Site 0023
Email not avaialable

Paris cedex 13,
France

Facility: Local Institution
Investigator:
Contact: Site 0038
Email not avaialable

Rennes Cedex,
France

Facility: Local Institution
Investigator:
Contact: Site 0102
Email not avaialable

Toulouse,
France

Facility: Local Institution
Investigator:
Contact: Site 0106
Email not avaialable

Vandoeuvre Les Nancy,
France

Facility: Local Institution
Investigator:
Contact: Site 0101
Email not avaialable

Petach Tikva,
Israel

Facility: Local Institution
Investigator:
Contact: Site 0096
Email not avaialable

Tel Aviv,
Israel

Facility: Local Institution
Investigator:
Contact: Site 0097
Email not avaialable

Bologna,
Italy

Facility: Local Institution
Investigator:
Contact: Site 0076
Email not avaialable

Milano,
Italy

Facility: Local Institution
Investigator:
Contact: Site 0079
Email not avaialable

Padova,
Italy

Facility: Local Institution
Investigator:
Contact: Site 0126
Email not avaialable

Rozzano (milano),
Italy

Facility: Local Institution
Investigator:
Contact: Site 0135
Email not avaialable

Siena,
Italy

Facility: Local Institution
Investigator:
Contact: Site 0078
Email not avaialable

Torino,
Italy

Facility: Azienda Ospedaliera Citta della Salute e della Scienza
Investigator:
Contact: Roberta Ruda, Site 0077
Email not avaialable

Tokyo,
Japan

Facility: Local Institution
Investigator:
Contact: Site 0112
Email not avaialable

Nagoya-shi, Aichi
Japan

Facility: Local Institution
Investigator:
Contact: Site 0115
Email not avaialable

Chiba-shi, Chiba
Japan

Facility: Local Institution
Investigator:
Contact: Site 0125
Email not avaialable

Hiroshima-Shi, Hiroshima
Japan

Facility: Local Institution
Investigator:
Contact: Site 0123
Email not avaialable

Sapporo-shi, Hokkaido
Japan

Facility: Local Institution
Investigator:
Contact: Site 0122
Email not avaialable

Kobe, Hyogo
Japan

Facility: Local Institution
Investigator:
Contact: Site 0129
Email not avaialable

Tsukuba-shi, Ibaraki
Japan

Facility: Local Institution
Investigator:
Contact: Site 0111
Email not avaialable

Kanazawa-shi, Ishikawa
Japan

Facility: Local Institution
Investigator:
Contact: Site 0121
Email not avaialable

Kagoshima-shi, Kagoshima
Japan

Facility: Local Institution
Investigator:
Contact: Site 0131
Email not avaialable

Sagamihara-shi, Kanagawa
Japan

Facility: Local Institution
Investigator:
Contact: Site 0133
Email not avaialable

Kumamoto-shi, Kumamoto
Japan

Facility: Local Institution
Investigator:
Contact: Site 0119
Email not avaialable

Kyoto-shi, Kyoto
Japan

Facility: Local Institution
Investigator:
Contact: Site 0117
Email not avaialable

Kyoto-shi, Kyoto
Japan

Facility: Local Institution
Investigator:
Contact: Site 0116
Email not avaialable

Okayama-shi, Okayama
Japan

Facility: Local Institution
Investigator:
Contact: Site 0134
Email not avaialable

Hirakata-shi, Osaka
Japan

Facility: Local Institution
Investigator:
Contact: Site 0120
Email not avaialable

Suita-shi, Osaka
Japan

Facility: Local Institution
Investigator:
Contact: Site 0130
Email not avaialable

Hidaka-shi, Saitama
Japan

Facility: Local Institution
Investigator:
Contact: Site 0113
Email not avaialable

Bunkyo-ku, Tokyo
Japan

Facility: Local Institution
Investigator:
Contact: Site 0128
Email not avaialable

Chuo-ku, Tokyo
Japan

Facility: Local Institution
Investigator:
Contact: Site 0114
Email not avaialable

Mitaka-shi, Tokyo
Japan

Facility: Local Institution
Investigator:
Contact: Site 0118
Email not avaialable

Yamagata-shi, Yamagata
Japan

Facility: Local Institution
Investigator:
Contact: Site 0110
Email not avaialable

Badalona-Barcelona,
Spain

Facility: Local Institution
Investigator:
Contact: Site 0027
Email not avaialable

Barcelona,
Spain

Facility: Local Institution
Investigator:
Contact: Site 0030
Email not avaialable

Barcelona,
Spain

Facility: Local Institution
Investigator:
Contact: Site 0028
Email not avaialable

Madrid,
Spain

Facility: Local Institution
Investigator:
Contact: Site 0029
Email not avaialable

Madrid,
Spain

Facility: Local Institution
Investigator:
Contact: Site 0031
Email not avaialable

Santiago De Compostela,
Spain

Facility: Local Institution
Investigator:
Contact: Site 0026
Email not avaialable

Valencia,
Spain

Facility: Local Institution
Investigator:
Contact: Site 0025
Email not avaialable




Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites